Sodium butyrate induces cell death by autophagy and reactivates a tumor suppressor gene DIRAS1 in renal cell carcinoma cell line UOK146

Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells

(2017) Hiromi Sato et al.   Oncology Letters

Autophagy and the Cell Cycle: A Complex Landscape

(2017) Søs Grønbæk Mathiassen et al.   Frontiers in Oncology

Aqueous Extract of Anticancer Drug CRUEL Herbomineral Formulation Capsules Exerts Anti-proliferative Effects in Renal Cell Carcinoma Cell Lines

(2016) Shiv Prakash Verma et al.   Asian Pacific Journal of Cancer Prevention

Abstract A43: DIRAS1 and DIRAS2 are tumor suppressor candidates that inhibit cell growth, motility, and proliferation while regulating autophagy in ovarian cancer.

(2016) Margie N. Sutton et al.   CLINICAL CANCER RESEARCH

The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases

(2016) Carmen Bergom et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis

(2016) Jintao Zhang et al.   PLoS One

Asparagus Racemosus Leaf Extract Inhibits Growth of UOK 146 Renal Cell Carcinoma Cell Line: Simultaneous Oncogenic PRCCTFE3 Fusion Transcript Inhibition and Apoptosis Independent Cell Death

(2014) Shiv Prakash Verma et al.   Asian Pacific Journal of Cancer Prevention

AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation

(2014) Valentina Cianfanelli et al.   NATURE CELL BIOLOGY

Downregulation of the Novel Tumor Suppressor DIRAS1 Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma

(2013) Y.-H. Zhu et al.   CANCER RESEARCH

Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro

(2013) HONG-GANG WANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: A paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma

(2013) MICHEL PINHEIRO DOS SANTOS et al.   ONCOLOGY REPORTS

Sodium Butyrate Induces Growth Inhibition and Apoptosis in Human Prostate Cancer DU145 Cells by Up-Regulation of the Expression of Annexin A1

(2013) Dawei Mu et al.   PLoS One

Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation

(2010) Kamil Gotfryd et al.   BMC CANCER

Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/phosphoinositide 3-kinase pathway

(2010) Zhigang Bai et al.   CELL BIOLOGY INTERNATIONAL

Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells

(2010) Masaki Kitazono et al.   CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib

(2009) Thinn P. Pwint et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The reduced catalase expression in TrkA-induced cells leads to autophagic cell death via ROS accumulation

(2008) S DADAKHUJAEV et al.   EXPERIMENTAL CELL RESEARCH